Document:

Amendment No. 5 to Lease and License Agreement, dated 01/25/2008

 Exhibit 10.20 

MARYLAND TECHNOLOGY DEVELOPMENT CENTER 

LICENSE AGREEMENT 

AMENDMENT 5 

This addendum is made this
25th day of January, 2008, by and between MEDCO and
Neogenix Oncology, Inc. (“Licensee”). 
 WHEREAS, MEDCO and Licensee have entered into a License Agreement dated
April 28, 2004; 
 WHEREAS, Licensee currently occupies Labs #211 and #222, and office #317 in the Maryland Technology
Development Center in Montgomery County, Maryland (the “Original Premises”); 
 WHEREAS Licensee wishes to expand its
space within the Maryland Technology Development Center and MEDCO is willing to provide for such expansion based on the terms provided for below; 

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows: 

 

	 	1.	MEDCO hereby grants to Licensee and Licensee hereby accepts a License (the “License”) to use an additional office spaces identified as offices #267 (“the
Expansion Premises”) effective February 1, 2008 

  

	 	2.	The additional monthly cash license payment resulting from the Expansion Premises (the “Monthly Payment”) shall be payable by Licensee in equal monthly
installments, on or before the first day of each month, and shall be as follows: 

  

				
	 From February 1, 2008 to April 30, 2008
	  	$	725
		
	 Renewal Term (If granted by MEDCO):
	  		
		
	 From May 1, 2008 to April 30, 2009:
	  	$	797

  

	 	3.	The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Expansion Premises provided for herein shall be as follows:

  

				
	 From February 1, 2008 to April 30, 2008
	  	$	9,351
		
	 Renewal Term (If granted by MEDCO):
	  		
		
	 From May 1, 2008 to April 30, 2009:
	  	$	10,286

	 	4.	On or before the Effective Date of this Amendment, Licensee shall pay to MEDCO a sum equal to one (1) Monthly Payment for the Expansion Premises, to be held by
MEDCO as security deposit for the full, faithful and punctual performance by Licensee’s terms, covenants and conditions contained herein for the full term of the License Agreement. At such time that this License Amendment commences, Licensee
shall be required to pay a sum of $725.00 as additional security deposit. 

  

	 	5.	All other provisions of the original License Agreement shall apply to this Amendment 

This Amendment may be signed in counterparts. 
  

									
	 FOR:
	 	 Maryland Economic

Development Corporation
	 		 	FOR:	 	 Licensee
 Neogenix Oncology,
Inc.

					
	 BY:
	 	
 

	 		 	BY:	 	
 

		 	 Scheer Partners, Inc.

Center Manager
	 		 		 	
					
	 Date:
	 	01/28/2008	 		 	Date:	 	Jan. 25, 2008
					
	 BY:
	 	 /s/ Robert C. Brennan
	 		 		 	
		 	 Robert C. Brennan
 Executive
Director, MEDCO
	 		 		 	
					
	 Date:
	 	2/4/08Amendment No. 6 to Lease and License Agreement, dated 03/21/2008

 Exhibit 10.21 

MARYLAND TECHNOLOGY DEVELOPMENT CENTER 

LICENSE AGREEMENT 

AMENDMENT 6 

This addendum is made this
21st day of March, 2008, by and between MEDCO and Neogenix
Oncology, Inc. (“Licensee”). 
 WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28,
2004; 
 WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #267 and #317 in the Maryland Technology
Development Center in Montgomery County, Maryland (the “Original Premises”); 
 WHEREAS Licensee wishes to expand its
space within the Maryland Technology Development Center and MEDCO is willing to provide for such expansion based on the terms provided for below; 

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows: 

 

	 	1.	MEDCO hereby grants to Licensee and Licensee hereby accepts a License (the “License”) to use an additional office spaces identified as offices #160 (“the
Expansion Premises”) with use of furniture already in office effective April 1, 2008. 

  

	 	2.	The additional monthly cash license payment resulting from the Expansion Premises (the “Monthly Payment”) shall be payable by Licensee in equal monthly
installments, on or before the first day of each month, and shall be as follows: 

  

					
	 From April 1, 2008 to April 30, 2009
	  	$
 ($
	405

380 rent + $25 furniture
	  
 ) 

	 Renewal Term (If granted by MEDCO):
	  			
		
	 From May 1, 2009 to April 30, 2010:
	  	$	445	  

  

	 	3.	The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Expansion Premises provided for herein shall be as follows:

  

				
	 From April 1, 2008 to April 30, 2009
	  	$	9,756
		
	 Renewal Term (If granted by MEDCO):
	  		
		
	 From May 1, 2009 to April 30, 2010:
	  	$	10,201

	 	4.	On or before the Effective Date of this Amendment, Licensee shall pay to MEDCO a sum equal to one (1) Monthly Payment for the Expansion Premises, to be held by
MEDCO as security deposit for the full, faithful and punctual performance by Licensee’s terms, covenants and conditions contained herein for the full term of the License Agreement. At such time that this License Amendment commences, Licensee
shall be required to pay a sum of $405.00 as additional security deposit. 

  

	 	5.	All other provisions of the original License Agreement shall apply to this Amendment 

This Amendment may be signed in counterparts. 
  

									
	 FOR:
	 	 Maryland Economic

Development Corporation
	 		 	FOR:	 	 Licensee
 Neogenix Oncology,
Inc.

					
	 BY:
	 	 /s/ Robyn Roberts
	 		 	BY:	 	
 

		 	 Scheer Partners, Inc.

Center Manager
	 		 		 	
					
	 Date:
	 	3/31/08	 		 	Date:	 	March 21, 2008
					
	 BY:
	 	 /s/ Robert C. Brennan
	 		 		 	
		 	 Robert C. Brennan
 Executive
Director, MEDCO
	 		 		 	
					
	 Date:
	 	4/7/08Amendment No. 7 to Lease and License Agreement, dated 08/11/2008

 Exhibit 10.22 

MARYLAND TECHNOLOGY DEVELOPMENT CENTER 

LICENSE AGREEMENT 

AMENDMENT 7 
 This
addendum is made this              day of             , 2008, by and between MEDCO and Neogenix Oncology, Inc.
(“Licensee”). 
 WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;

 WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #160, #267 and #317 in the Maryland Technology
Development Center in Montgomery County, Maryland (the “Original Premises”); 
 WHEREAS Licensee wishes to expand and
relocate its space within the Maryland Technology Development Center and MEDCO is willing to provide for such expansion based on the terms provided for below; 

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows: 

 

	 	1.	MEDCO hereby grants to Licensee and Licensee hereby accepts a License (the “License”) to use an additional office spaces identified as offices #132, #261 and
#262 (“the Expansion Premises”) effective August 1, 2008. 

  

	 	2.	MEDCO hereby grants to Licensee and Licensee hereby accepts to vacate office space identified as offices #160 effective July 31, 2008. 

 

	 	3.	The additional monthly cash license payment resulting from the Expansion Premises (the “Monthly Payment”) shall be payable by Licensee in equal monthly
installments, on or before the first day of each month, and shall be as follows: 

  

	 	4.	The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Expansion Premises provided for herein shall be as follows:

  

				
	 From August 1, 2008 to April 30, 2009
	  	$	10,531
		
	 Renewal Term (If granted by MEDCO):
	  		
		
	 From May 1, 2009 to April 30, 2010:
	  	$	11,584

  

	 	5.	 On or before the Effective Date of this Amendment, Licensee shall pay to MEDCO a sum equal to one (1) Monthly Payment for the Expansion

	 	
Premises, to be held by MEDCO as security deposit for the full, faithful and punctual performance by Licensee’s terms, covenants and conditions contained herein for the full term of the
License Agreement. At such time that this License Amendment commences, Licensee shall be required to pay a sum of $775.00 as additional security deposit. 

  

	 	6.	All other provisions of the original License Agreement shall apply to this Amendment 

This Amendment may be signed in counterparts. 
  

									
	 FOR:
	 	 Maryland Economic

Development Corporation
	 		 	FOR:	 	 Licensee
 Neogenix Oncology,
Inc.

					
	 BY:
	 	 /s/ Robyn Sanches
	 		 	BY:	 	
 

		 	 Scheer Partners, Inc.

Center Manager
	 		 		 	C.F.O.
					
	 Date:
	 	8/5/08	 		 	Date:	 	7-18-08
					
	 BY:
	 	 /s/ Robert C. Brennan
	 		 		 	
		 	 Robert C. Brennan
 Executive
Director, MEDCO
	 		 		 	
					
	 Date:
	 	8/11/08Amendment No. 9 to Lease and License Agreement, dated 04/30/2009

 Exhibit 10.23 

MARYLAND TECHNOLOGY DEVELOPMENT CENTER 

LICENSE AGREEMENT 

AMENDMENT 9 
 This
addendum is made this 30 day of April, 2009, by and between MEDCO and Neogenix Oncology, Inc. (“Licensee”). 

WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004; 

WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #132, #261, #262, #267 and #317 in the Maryland Technology
Development Center in Montgomery County, Maryland (the “Original Premises”); 
 WHEREAS Licensee wishes to reduce its
office space within the Maryland Technology Development Center and MEDCO is willing to provide for such reduction based on the terms provided for below; 

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows: 

 

	 	1.	Effective May 31, 2009, Licensee shall vacate office #132 (the “Reduction Premises”). 

 

	 	2.	The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows:

  

				
	 From June 1, 2009 to April 30, 2010
	  	$	10,161
		
	 Renewal Term (if granted by MEDCO) From June 1, 2010 to April 30, 2011
	  	$	11,177

  

	 	3.	All other provisions of the original License Agreement shall apply to this Amendment 

 This Amendment may be signed in counterparts. 

 

									
	 FOR:
	 	 Maryland Economic

Development Corporation
	 		 	FOR:	 	Neogenix Oncology, Inc.
					
	 BY:
	 	 /s/ Robyn Sanches
	 		 	BY:	 	
 

		 	 Scheer Partners, Inc.

Center Manager
	 		 		 	
					
	 Date:
	 	5/22/09	 		 	Date:	 	4/30/09
					
	 BY:
	 	 /s/ Robert C. Brennan
	 		 		 	
		 	 Robert C. Brennan
 Executive
Director, MEDCO
	 		 		 	
					
	 Date:
	 	6/3/09

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]